Glass House Brands Inc.

GLAS NYSE SEC CIK 1848731
Follow Glass House Brands Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$100M$0$100M$200M$300MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$182M−$29.7M
FY24$200.9M$519K
FY23$160.8M−$98.3M
FY22$84.9M−$32.9M
FY21$63.2M−$43.1M
FY20$48.3M−$16.7M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2542.3%−9.1%−16.3%
FY2448.5%2.9%0.3%
FY2350.3%−30.8%−61.1%
FY2224.4%−66.4%−38.8%
FY2125%−57.2%−68.2%
FY2038.8%−12.4%−34.5%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0$50MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$15.7M
FY24$18.1M
FY23$10.9M
FY22−$68.6M
FY21−$128.8M
FY20−$11.5M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Glass House Brands
  • Healthcare median
−100%−75%−50%−25%0%25%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGlass House BrandsHealthcare median
FY25−16.3%−30.6%
FY240.3%−47%
FY23−61.1%−58%
FY22−38.8%−80.4%
FY21−68.2%−71.9%
FY20−34.5%−62.2%
FY19-−46.3%